Tower Bridge Advisors’s GSK GSK Stock Holding History

Tower Bridge Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,004	Closed	-$249K	–	210
2023 Q1	$249K	Sell	7,004 -1,940	-22%	-$67.9K	0.02%	213
2022 Q4	$314K	Hold	8,944	–	–	0.03%	204
2022 Q3	$263K	Sell	8,944 -3,362	-27%	-$127K	0.02%	210
2022 Q2	$670K	Buy	12,306 +179	+1%	+$9.88K	0.05%	164
2022 Q1	$660K	Sell	12,127 -2,087	-15%	-$113K	0.04%	181
2021 Q4	$784K	Sell	14,214 -1,140	-7%	-$59.3K	0.05%	175
2021 Q3	$733K	Sell	15,354 -160	-1%	-$8.04K	0.05%	177
2021 Q2	$772K	Buy	15,514 +80	+0.5%	+$3.84K	0.05%	171
2021 Q1	$689K	Sell	15,434 -540	-3%	-$24.5K	0.05%	167
2020 Q4	$735K	Buy	15,974 +287	+2%	+$13.2K	0.06%	151
2020 Q3	$738K	Hold	15,687	–	–	0.08%	126
2020 Q2	$800K	Sell	15,687 -400	-2%	-$20.5K	0.09%	116
2020 Q1	$762K	Hold	16,087	–	–	0.1%	119
2019 Q4	$945K	Sell	16,087 -1,088	-6%	-$60.5K	0.1%	121
2019 Q3	$954K	Hold	17,175	–	–	0.1%	120
2019 Q2	$859K	Hold	17,175	–	–	0.1%	128
2019 Q1	$897K	Sell	17,175 -160	-0.9%	-$8K	0.1%	124
2018 Q4	$828K	Sell	17,335 -319	-2%	-$15.7K	0.11%	120
2018 Q3	$886K	Hold	17,654	–	–	0.09%	128
2018 Q2	$890K	Hold	17,654	–	–	0.1%	123
2018 Q1	$862K	Sell	17,654 -1,964	-10%	-$91.5K	0.1%	125
2017 Q4	$870K	Buy	19,618 +2,071	+12%	+$95.7K	0.09%	124
2017 Q3	$891K	Buy	17,547 +1	+0%	+$51	0.1%	120
2017 Q2	$946K	Sell	17,546 -160	-0.9%	-$8.53K	0.11%	118
2017 Q1	$933K	Sell	17,706 -840	-5%	-$42.6K	0.11%	117
2016 Q4	$893K	Sell	18,546 -1,600	-8%	-$79K	0.11%	120
2016 Q3	$1.09M	Hold	20,146	–	–	0.13%	112
2016 Q2	$1.09M	Sell	20,146 -1,040	-5%	-$54.8K	0.14%	110
2016 Q1	$1.07M	Buy	21,186 +520	+3%	+$25.9K	0.13%	108
2015 Q4	$1.04M	Sell	20,666 -1,524	-7%	-$77.7K	0.14%	108
2015 Q3	$1.07M	Buy	22,190 +1,044	+5%	+$54.3K	0.15%	103
2015 Q2	$1.1M	Sell	21,146 -1,519	-7%	-$85.5K	0.14%	106
2015 Q1	$1.31M	Sell	22,665 -812	-3%	-$46.6K	0.17%	102
2014 Q4	$1.25M	Buy	23,477 +492	+2%	+$27.5K	0.15%	107
2014 Q3	$1.32M	Sell	22,985 -120	-0.5%	-$7.36K	0.17%	103
2014 Q2	$1.54M	Hold	23,105	–	–	0.19%	96
2014 Q1	$1.54M	Sell	23,105 -500	-2%	-$33.8K	0.2%	94
2013 Q4	$1.58M	Sell	23,605 -448	-2%	-$29K	0.21%	91
2013 Q3	$1.51M	Hold	24,053	–	–	0.22%	93
2013 Q2	$1.5M	Buy	+24,053	New	+$1.53M	0.22%	91

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Bridge Advisors's GSK Position: Q2 2023 in Review

Tower Bridge Advisors sold out of GSK (GSK) in Q2 2023, closing a stake of 7,004 shares — an estimated $249K sold.

Tower Bridge Advisors first reported a position in GSK in Q2 2013 and held it in 40 quarters. The position peaked at $1.58M in Q4 2013. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Tower Bridge Advisors reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
Tower Bridge Advisors sold 7,004 GSK shares in Q2 2023, an estimated $249K.
Tower Bridge Advisors first reported a position in GSK in Q2 2013 and held it in 40 quarters.
Tower Bridge Advisors's GSK position peaked at $1.58M in Q4 2013.
827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Tower Bridge Advisors's 13F filing for Q2 2023, filed 20 Jul 2023.